These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2207221)

  • 21. Nutrition, serotonin and behavior in anorexia and bulimia nervosa.
    Kaye W; Gendall K; Strober M
    Nestle Nutr Workshop Ser Clin Perform Programme; 2001; 5():153-65; discussion 165-8. PubMed ID: 11510436
    [No Abstract]   [Full Text] [Related]  

  • 22. [Selected issues of biological aspects of eating disorders].
    Włodarczyk-Bisaga K; Bisaga A
    Psychiatr Pol; 1994; 28(5):579-91. PubMed ID: 7991711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anorexia nervosa, obsessional behavior, and serotonin.
    Kaye WH
    Psychopharmacol Bull; 1997; 33(3):335-44. PubMed ID: 9550876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low density and high affinity of platelet [3H]paroxetine binding in women with bulimia nervosa.
    Ekman A; Sundblad-Elverfors C; Landén M; Eriksson T; Eriksson E
    Psychiatry Res; 2006 Jun; 142(2-3):219-23. PubMed ID: 16690136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.
    Brewerton TD; Mueller EA; Lesem MD; Brandt HA; Quearry B; George DT; Murphy DL; Jimerson DC
    Arch Gen Psychiatry; 1992 Nov; 49(11):852-61. PubMed ID: 1444722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, psychopathological and personality correlates of interoceptive awareness in anorexia nervosa, bulimia nervosa and obesity.
    Fassino S; Pierò A; Gramaglia C; Abbate-Daga G
    Psychopathology; 2004; 37(4):168-74. PubMed ID: 15237246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common biological pathways in eating disorders and obesity.
    Ericsson M; Poston WS; Foreyt JP
    Addict Behav; 1996; 21(6):733-43. PubMed ID: 8904939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial.
    Faris PL; Kim SW; Meller WH; Goodale RL; Oakman SA; Hofbauer RD; Marshall AM; Daughters RS; Banerjee-Stevens D; Eckert ED; Hartman BK
    Lancet; 2000 Mar; 355(9206):792-7. PubMed ID: 10711927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eating disorders in females: genetics, pathophysiology, and treatment.
    Halmi KA
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1379-86. PubMed ID: 12510994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in neuroimaging to model eating disorder neurobiology.
    Frank GK
    Curr Psychiatry Rep; 2015 Apr; 17(4):559. PubMed ID: 25749747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa.
    Kaye W; Gendall K; Strober M
    Biol Psychiatry; 1998 Nov; 44(9):825-38. PubMed ID: 9807638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled family study of anorexia nervosa and bulimia nervosa: psychiatric disorders in first-degree relatives and effects of proband comorbidity.
    Lilenfeld LR; Kaye WH; Greeno CG; Merikangas KR; Plotnicov K; Pollice C; Rao R; Strober M; Bulik CM; Nagy L
    Arch Gen Psychiatry; 1998 Jul; 55(7):603-10. PubMed ID: 9672050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Food and mood: relationship between food, serotonin and affective disorders.
    Wallin MS; Rissanen AM
    Acta Psychiatr Scand Suppl; 1994; 377():36-40. PubMed ID: 8053364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New directions in treatment research of anorexia and bulimia nervosa.
    Kaye W; Strober M; Stein D; Gendall K
    Biol Psychiatry; 1999 May; 45(10):1285-92. PubMed ID: 10349034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orexigenic/anorexigenic signals in bulimia nervosa.
    Takimoto Y; Inui A; Kumano H; Kuboki T
    Curr Mol Med; 2003 Jun; 3(4):349-60. PubMed ID: 12776990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin function following remission from bulimia nervosa.
    Wolfe BE; Metzger ED; Levine JM; Finkelstein DM; Cooper TB; Jimerson DC
    Neuropsychopharmacology; 2000 Mar; 22(3):257-63. PubMed ID: 10693153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropeptides in eating disorders.
    Jimerson DC; Wolfe BE
    CNS Spectr; 2004 Jul; 9(7):516-22. PubMed ID: 15208511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eating disorders: a review of the literature with emphasis on medical complications and clinical nutrition.
    Patrick L
    Altern Med Rev; 2002 Jun; 7(3):184-202. PubMed ID: 12126461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced platelet [3H]paroxetine binding in anorexia nervosa: relationship to eating symptoms and personality pathology.
    Bruce KR; Steiger H; Ng Ying Kin NM; Israel M
    Psychiatry Res; 2006 Jun; 142(2-3):225-32. PubMed ID: 16697471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothalamic digoxin, hemispheric chemical dominance, and eating behavior.
    Kurup RK; Kurup PA
    Int J Neurosci; 2003 Aug; 113(8):1127-41. PubMed ID: 12888426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.